Mumps

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2025-10-30
EMA Authorised: M-M-RVaxPro (measles virus Enders’ Edmonston strain (live, attenuated);mumps virus Jeryl Lynn (level B) strain (live, attenuated);rubella virus Wistar RA 27/3 strain (live, attenuated)) — Merck Sharp & Dohme B.V.
The EMA authorised Merck's M-M-RVaxPro, a live attenuated measles‑mumps‑rubella vaccine, for immunization against measles, mumps and rubella…
EMA approval · 2025-09-25
EMA Authorised: ProQuad (virus, live attenuated, measles, virus, live attenuated, mumps, virus, live attenuated, rubella, virus, live attenuated, varicella) — Merck Sharp & Dohme B.V.
EMA has authorized ProQuad, a live attenuated vaccine that protects against varicella (chickenpox), measles, mumps and rubella in the Europe…